BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Annual General Meeting in ALK on 23 March 2023

  The Annual General Meeting of ALK-Abelló A/S will take place on Thursday, 23 March 2023 at 4:00 PM at ALK-Abelló A/S, 1 Bøge Allé, 2970 Hørsholm, Denmark.

  February 27, 2023

   · 

  1 min read
• Pharm Country

  Krystal Biotech Announces Fourth Quarter and Full Year 2022 Financial Results and Operational Progress

  Krystal Biotech, Inc. today reported financial results and key operational updates for the fourth quarter and year ending December 31, 2022.

  February 27, 2023

   · 

  9 min read
• Business

  Axsome Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

  Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today reported financial results for the fourth quarter and full year ended December 31, 2022.

  February 27, 2023

   · 

  17 min read
• Pharm Country

  CytoSorbents to Present at the Cowen 43rd Annual Health Care Conference

  CytoSorbents Corporation announces that Dr. Phillip Chan , Chief Executive Officer, will present at the Cowen 43rd Annual Health Care Conference at the Boston Marriott Copley Place, in Boston, MA on Tuesday, March 7, 2023.

  February 27, 2023

   · 

  5 min read
• Business

  Compugen Reports Fourth Quarter and Full Year 2022 Results

  Compugen Ltd. (Nasdaq: CGEN), (“Compugen”, the “Company”), a clinical-stage cancer immunotherapy company and pioneer in computational target discovery, today reported financial results for the fourth quarter and full year 2022 and provided an update on its main highlights from 2022 and future plans.

  February 27, 2023

   · 

  12 min read
• Genetown

  Seres Therapeutics to Participate in Cowen 43rd Annual Health Care Conference

  Seres Therapeutics, Inc. today announced that Eric Shaff, President and Chief Executive Officer of Seres Therapeutics, will participate in a panel discussion at the Cowen 43rd Annual Health Care Conference on Monday, March 6, 2023 at 9:10 a.m. ET.

  February 27, 2023

   · 

  1 min read